Genetic Testing for Hereditary Cancer

Suitable for high-risk individuals with family history.

Female : 74 genes

Male : 79 genes

 (DX0645/DX0646)

$3,240

Working Hours

Monday to Friday:9 am – 6 pm
Saturday:9 am – 1 pm
Sunday and Public Holiday:Closed

eHealth System & Health Care Voucher

We can upload images to eHRSS.
We support the use of Health Care Voucher.

More Information
Testing Content
Details

Female : (74 genes)

Breast, Ovarian, Colorectal, Melanoma, Gastric, Endometrial, Renal, Pancreatic, Bladder, Thyroid, Parathyroid, Multiple Endocrine Neoplasia, Neuofibromatosis, Pheochromocytoma, Familial Paraganglioma, Rentinoblastoma, Chondrosarcoma, Gastrointestinal Stromal, Urothelial Carcinoma, Tuberous Sclerosis, Nephroblastoma,  Neuroblastoma, Nevoid Basal Cell Carcinoma

Male : (79 genes)

Breast, Prostate, Colorectal, Melanoma, Gastric, Renal,  Pancreatic, Bladder, Thyroid, Parathyroid, Multiple Endocrine Neoplasia, Neuofibromatosis, Pheochromocytoma, Familial Paraganglioma, Rentinoblastoma, Chondrosarcoma, Gastrointestinal Stromal, Urothelial Carcinoma, Tuberous Sclerosis, Nephroblastoma,  Neuroblastoma, Nevoid Basal Cell Carcinoma

Why check for Hereditary Cancers?
Details

Genetic testing to identify hereditary cancers allows you to prevent and manage your health early.

Hereditary cancers account for approximately 5-10% of all cancers, and people who inherit genetic mutations generally are more likely to develop certain cancers at earlier age of onset than the common population.

Who should take Hereditary Cancer Tests?

  • Personal or family medical history characteristics, especially if they meet more than one of the following, the body may have hereditary cancer genes:
  • Two or more family members have breast cancer or ovarian cancer
  • Early-onset breast cancer was diagnosed in the family (under 45 years old)
  • The same person in the family has multiple breast cancers, or has breast cancer and ovarian cancer successively
  • A male in the family is a breast cancer patient
  • Patients with breast cancer or ovarian inflammation